FOLH1 and neoplasm: Moreover, PET-based parameters like PSMA-TV and TL-PSMA, although significantly different between groups (in the fourth cycle assessment), did not keep their level of significance when compared to the more significant parameters (e.g. tumour-to-background ratios) in the therapy response prediction.